tiprankstipranks
Genscript Reports on Legend Biotech’s Q3 Financials
Company Announcements

Genscript Reports on Legend Biotech’s Q3 Financials

Genscript Biotech (HK:1548) has released an update.

Don't Miss Our Christmas Offers:

Genscript Biotech Corporation announced the unaudited financial results for the third quarter of 2024 for its associate, Legend Biotech Corporation, which holds a 47.56% stake in the company. Legend Biotech, listed on the Nasdaq Global Selected Market, has filed its results with the SEC, highlighting important business developments. Investors are advised to consider potential risks when dealing with Genscript’s securities.

For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech Boosts Stake in Probio Cayman
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech Announces CEO Resignation and Leadership Changes
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App